Browsing School of Medicine (Sch. of Med.) by Subject "Dolutegravir"
Now showing items 1-3 of 3
-
Prevalence and factors associated with Dolutegravir-related hyperglycemia among children and adolescents <18 years attending Soroti Regional Referral and Lira Regional Referral Hospitals
(Makerere University, 2023-07)Background: The World Health Organization (WHO) recommended Dolutegravir (DTG) as the preferred anchor drug in first and second line Anti-Retroviral Treatment (ART) regimens owing to its high genetic barrier to resistance, ... -
Prevalence and factors influencing suboptimal adherence to dolutegravir-based regimens among adult patients at Joint Clinical Research Center, Lubowa
(Makerere University, 2022-12)Background: An estimated 37.7 million people are living with HIV globally with the majority being in sub-Saharan Africa. There is a need to address suboptimal adherence to prevent dolutegravir resistance in order to maintain ... -
Prevalence of neuropsychiatric adverse events and associated factors among adult patients on Dolutegravir attending Mulago ISS clinic.
(Makerere University, 2022-02)Introduction: Dolutegravir (DTG) is a second-generation integrase strand transfer inhibitor that is recommended by World Health Organization for use as the preferred first line and second line anti-retroviral regimen ...